(Q33797142)

29 July 2017

title

Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial (English)

1 reference

29 July 2017

0 references

1 reference

2

Connie Celum

1 reference

29 July 2017

Sinead Delany-Moretlwe

8

Sinead Delany-Moretlwe

1 reference

29 July 2017

9

Lawrence Corey

1 reference

29 July 2017

Stewart Reid

7

0 references

Frances M. Cowan

Frances Cowan

6

0 references

Anna Wald

Anna Wald

10

0 references

Jonathan Fuchs

1

Jonathan Fuchs

1 reference

29 July 2017

4

James Hughes

1 reference

29 July 2017

Jing Wang

3

1 reference

29 July 2017

Jorge Sanchez

5

1 reference

29 July 2017

HIV Prevention Trials Network 039 Protocol Team

11

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

Journal of Infectious Diseases

29 July 2017

published in

1 reference

29 July 2017

volume

201

1 reference

29 July 2017

issue

8

1 reference

29 July 2017

page(s)

1164-1168

1 reference

Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

Effect of herpes simplex suppression on incidence of HIV among women in Tanzania

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

Practical and conceptual challenges in measuring antiretroviral adherence

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

Divergence and recombination of clinical herpes simplex virus type 2 isolates

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856478

30 October 2018

Identifiers

DOI

10.1086/651381

1 reference

29 July 2017

1 reference

29 July 2017

1 reference